Jyong Biotech Ltd (MENS)

Jul 03, 2026

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention - Macau Business

Jul 03, 2026

Jul 02, 2026

Jyong Biotech presents drug candidate at BIO 2026 convention By Investing.com - Investing.com Nigeria

Jul 02, 2026

Jul 02, 2026

Jyong Biotech presents drug candidate at BIO 2026 convention - Investing.com

Jul 02, 2026

Jul 02, 2026

Jyong Biotech advances botanical drug Botreso® at BIO 2026, targeting global licensing for BPH treatment. - Pluang

Jul 02, 2026

Jul 02, 2026

Jyong Biotech pitched its plant-based BPH drug to pharma partners at BIO 2026 - Stock Titan

Jul 02, 2026

Jun 30, 2026

Jyong Biotech (MENS) Retreats Over 5% as Key Support Test LoomsForce Index - dars.gov.et

Jun 30, 2026

Jun 26, 2026

Price to sales forward of Jyong Biotech Ltd. – NASDAQ:MENS - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to EBIT forward of Jyong Biotech Ltd. – NASDAQ:MENS - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to EBITDA forward of Jyong Biotech Ltd. – NASDAQ:MENS - TradingView

Jun 26, 2026

Jun 26, 2026

Price to book forward of Jyong Biotech Ltd. – NASDAQ:MENS - TradingView

Jun 26, 2026

Jun 23, 2026

Jyong Biotech Ltd (MENS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026

Jun 17, 2026

Jyong Biotech Ltd (MENS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Jyong Biotech Ltd (MENS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

Jyong Biotech Ltd (MENS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Jyong Biotech Ltd (MENS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

Number of shareholders of Jyong Biotech Ltd. – NASDAQ:MENS - TradingView

Jun 17, 2026

Jun 16, 2026

Jyong Biotech Ltd (MENS) Institutional Confidence - TradingKey

Jun 16, 2026

Jun 16, 2026

Jyong Biotech Ltd (MENS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 16, 2026

Jun 16, 2026

Jyong Biotech Ltd (MENS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 16, 2026

Jun 16, 2026

Jyong Biotech Ltd (MENS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 16, 2026

Jun 15, 2026

Certain Ordinary Shares of Jyong Biotech Ltd. are subject to a Lock-Up Agreement Ending on 16-JUN-2026. - marketscreener.com

Jun 15, 2026

Jun 05, 2026

JYONG BIOTECH LTD (MENS) Stock Chart - ChartMill

Jun 05, 2026

May 31, 2026

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview - digitalmore.co

May 31, 2026

May 29, 2026

Jyong Biotech outlines FDA approval path for botanical drug Botreso® targeting benign prostatic hyperplasia. - Pluang

May 29, 2026

May 27, 2026

Jyong Biotech (MENS) Remains Range-Bound as Price Consolidates Near SupportPut Flow Alert - The Legal Advocate

May 27, 2026

May 27, 2026

MENSJyong Biotech Ltd Stock Price and Quote - Finviz

May 27, 2026

May 25, 2026

Jyong Biotech Ltd. (MENS) Surges 3.37% as Buyers Defend Key Support LevelTake Profit Levels - The Legal Advocate

May 25, 2026

May 25, 2026

Jyong Biotech Ltd. (MENS) Shows Resilience: Uptick from Key Support ZoneImbalance Zone - The Legal Advocate

May 25, 2026

May 23, 2026

Jyong Biotech Ltd. (MENS) Gains 3.37% as Technical Support Holds, Resistance in FocusIV Rank - Newser

May 23, 2026

May 22, 2026

Jyong Biotech Ltd. (MENS) Stabilizes Near Key Support After Modest UptickIchimoku TK Cross - Newser

May 22, 2026

May 21, 2026

MENS Stock Price, Quote & Chart | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

May 21, 2026

May 18, 2026

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - marketscreener.com

May 18, 2026

May 15, 2026

Jyong Biotech (NASDAQ: MENS) flags Botreso FDA hurdles and $19.4M judgment - Stock Titan

May 15, 2026

May 15, 2026

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year Ended December 31, 2025 - Quiver Quantitative

May 15, 2026

May 15, 2026

DXS INTERNATIONAL PLC (AQSE: DXSP): Issue of New Shares and Notification of Director / PDMR Dealings - Weekly Voice

May 15, 2026

May 14, 2026

Jyong Biotech Ltd. Auditor Raises 'Going Concern' Doubt - marketscreener.com

May 14, 2026

May 11, 2026

What Jyong Biotech (MENS) management focus reveals about priorities (Risk Aversion) 2026-05-11Crowd Sentiment Stocks - Newser

May 11, 2026

Apr 30, 2026

Jyong Biotech Delays Annual 20-F (Yearly Report) - The Globe and Mail

Apr 30, 2026

Apr 28, 2026

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio - The Manila Times

Apr 28, 2026

Apr 28, 2026

Jyong Biotech Updates Market Access Strategy for Innovative - GlobeNewswire

Apr 28, 2026

Apr 27, 2026

Short Interest in Jyong Biotech Ltd. (NASDAQ:MENS) Decreases By 43.2% - MarketBeat

Apr 27, 2026

Apr 24, 2026

CEO-linked entities report 33.34% Jyong Biotech (MENS) stake via trust - Stock Titan

Apr 24, 2026

Apr 22, 2026

Jyong Biotech (MENS) Management Strategy | Q1 2025: Earnings ReportPre Earnings - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 20, 2026

Who Backs Jyong Biotech (MENS) Stock (Risk Aversion) 2026-04-20Investment Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Apr 18, 2026

Ming Tsan Hsu Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Pang Chieh Chi Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Hung Shu Fan Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Feng Lin Hsu Net Worth (2026) - GuruFocus

Apr 18, 2026